Science

Max Q: Get in loser, we’re smashing a spacecraft into an asteroid

Hello and welcome back to Max Q! I hope everyone had a wonderful Thanksgiving-slash-holiday weekend. It’s more than a little mind-boggling that we’re reaching the end of 2021, but that onl

Perfeggt brings in first capital to shell out plant-based egg alternative

Worldwide, over 1.3 trillion eggs are produced annually, and Perfeggt co-founders believe this market is largely untapped and has room to grow with plant-based alternatives.

Longevica takes in $2.5M as it launches open research resources to examine life extension

Longevica's goal is to validate the pipeline of turning scientific research into consumer-ready products.

Tiamat Sciences cooking up plant-based proteins for cheaper production of cellular meat

Adil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others, that cost could come down 10 times.

‘Armageddon’ now: NASA’s asteroid-deflecting DART mission launches tonight

Update: Successful launch and NASA has acquired DART’s signal. One of NASA’s most exciting and unusual missions in years, the Double Asteroid Redirection Test (DART), is scheduled to launc

UK-based mental health provider ieso raises $53M armed with an ‘unprecedented’ data set

U.K.-based digital therapy company ieso announced a $53 million Series B round on Tuesday. The round is the funding the company needs to move in a brand new direction: creating more intuitive autonomo

Helaina’s latest round brings it closer to market with human milk-equivalent baby formula

Helaina is tapping into a precision fermentation process that programs yeast cells and teaches them to become manufacturing hubs to develop almost identical proteins found in human milk.

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines

EasyHealth, a startup targeting the Medicare experience, announces $135M Series A

EasyHealth, a startup focused on navigating the Medicare experience, announced a $135 million Series A round on Thursday. EasyHealth has a simple purpose: to help enroll, and follow-up with (more on t

With new tech and $3.6M seed, DiviGas aims to clean up hydrogen production

Hydrogen is at the center of many industrial processes and potentially part of major future energy ecosystems, but the process of isolating and storing it is wasteful and expensive. DiviGas, armed wit

H1 closes $100M Series C on the back of ‘incredible traction’ and a successful first use case

Fresh off of a $58 million Series B round, and just one year after graduating from Y combinator, H1, a “LinkedIn for the healthcare industry” has raised even more cash. On Tuesday, the company ann

Max Q: No (American) boots on the moon until 2025, NASA says

Hello and welcome back to Max Q! I know I said this last week, but TC Sessions: Space is right around the corner and we’d love for you to join. You can find a sneak peek of the agenda at the bot

Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups

Each year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But there’s a gap between the people who need treatment and t

Why quantum ‘utility’ should replace quantum advantage

Similar to the first transistors at the dawn of classical computing, the key technical challenge to achieving widespread quantum utility will be in the fabrication of integrated quantum chips.

Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs

In Frequency Therapeutics’ short lifetime as a company, it’s had its ups and downs. On Tuesday, during an R&D event day, the company unleashed a slew of announcements that add context to the d

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’

On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, cal

AKUA lands $3.2M to turn kelp into burgers

AKUA aims to replace the unsustainable part of food — factory farming — with regenerative ocean farming.

An accelerator and fund says it’s giving away its voting rights to scientist founders

SciFounders, an accelerator program and fund launched back in January with $6 million in backing, has a new proposition for the scientist founders who it looks to help run their own companies. It plan

Isomorphic Labs is Alphabet’s play in AI drug discovery

The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information pro

Federal judge quashes Bezos’ lawsuit against NASA over SpaceX contract

A federal judge has dismissed a lawsuit brought by Jeff Bezos’ Blue Origin against NASA over the agency’s decision to award a lunar lander contract to Elon Musk’s SpaceX earlier this year. The d
Load More